Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.

Published byHugh Ryan Modified over 6 years ago

Similar presentations

Presentation on theme: "Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern."— Presentation transcript:

1 Table 1 Characteristics of study patients in survey of HIV infection in India.
From: Natural History of Human Immunodeficiency Virus Disease in Southern India Clin Infect Dis. 2003;36(1): doi: /344756 Clin Infect Dis | © 2003 by the Infectious Diseases Society of America

2 Table 2 Findings of univariate Cox regression for all factors relating to survival of patients with AIDS in survey in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern India Clin Infect Dis. 2003;36(1): doi: /344756 Clin Infect Dis | © 2003 by the Infectious Diseases Society of America

3 Table 3 Findings of multivariate Cox regression analysis relating to survival of patients with AIDS after adjusting for sex, mode of transmission, age, CD4 lymphocyte count, presence of any opportunistic infection (OI), use of trimethoprim-sulfamethoxazole (TMP-SMZ) prophylaxis, and antiretroviral therapy. From: Natural History of Human Immunodeficiency Virus Disease in Southern India Clin Infect Dis. 2003;36(1): doi: /344756 Clin Infect Dis | © 2003 by the Infectious Diseases Society of America

4 Figure 1 Cumulative survival rate for persons with baseline CD4 cell counts of <200 cells/μL who did or did not receive antiretroviral therapy (ART). The mean duration of survival for persons who received ART (n = 141) was 46 months (median, 45 months); for those who did not receive ART, the mean duration of survival was 27 months (median, 33 months; P <.001). From: Natural History of Human Immunodeficiency Virus Disease in Southern India Clin Infect Dis. 2003;36(1): doi: /344756 Clin Infect Dis | © 2003 by the Infectious Diseases Society of America

Download ppt "Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern."

Similar presentations

Poster 810 Race and Sex Differences in HAART Use and Mortality among HIV-infected Persons in Care DC Lemly 1, BE Shepherd 1, TM Hulgan 1, P Rebeiro 1,

Poster 810 Race and Sex Differences in HAART Use and Mortality among HIV-infected Persons in Care DC Lemly 1, BE Shepherd 1, TM Hulgan 1, P Rebeiro 1,
XX Años Tratando el VIH 1986-2006 Josep Mallolas Servei d´Infeccions Hospital Clínic.

XX Años Tratando el VIH Josep Mallolas Servei d´Infeccions Hospital Clínic.
A Survival Comparison between HIV+ U.S.-born Latinos and Foreign-born Latinos in Houston, Texas 1990 - 2001 Raouf Arafat, MD, MPH, Adebowale Awosika- Olumo.

A Survival Comparison between HIV+ U.S.-born Latinos and Foreign-born Latinos in Houston, Texas Raouf Arafat, MD, MPH, Adebowale Awosika- Olumo.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.

CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Antiretroviral Therapy on Viral Load, CD4.

Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Antiretroviral Therapy on Viral Load, CD4.
Figure 1 Overview of Markov model for infected total hip arthroplasty

Figure 1 Overview of Markov model for infected total hip arthroplasty
Earlier treatment and lower mortality in infants Initiating ART at

Earlier treatment and lower mortality in infants Initiating ART at
Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.
Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
Table 1. Baseline Characteristics of the 36,636 Study Subjects

Table 1. Baseline Characteristics of the 36,636 Study Subjects
Copyright © 2017 American Academy of Pediatrics.

Copyright © 2017 American Academy of Pediatrics.
International Journal of Infectious Diseases

International Journal of Infectious Diseases
Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.
Figure 1 Inclusion criteria, exclusion criteria, and criteria for virologic failure. CDC, Centers for Disease Control and Prevention; ddC, zalcitabine;

Figure 1 Inclusion criteria, exclusion criteria, and criteria for virologic failure. CDC, Centers for Disease Control and Prevention; ddC, zalcitabine;
Table 1 Characteristics of patients at enrollment who received artesunate-amodiaquine (ASAQ) or artemether-lumefantrine (AL) for treatment of malaria.

Table 1 Characteristics of patients at enrollment who received artesunate-amodiaquine (ASAQ) or artemether-lumefantrine (AL) for treatment of malaria.
Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.

Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.

Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.
Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.

Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.

Similar presentations

Ads by Google